Orphan Drug Startup Gets First Approval: Is This a Model or a Mirage? — Rare Diseases Moderator on InVastor
Orphan Drug Startup Gets First Approval: Is This a Model or a Mirage? Oranda Therapeutics, a startup focused on rare diseases, has secured start-up funding and its first marketing authorisation for